Tianyu Co., Ltd. said on an interactive platform on November 11 that the company recently underwent an on-site inspection by the US FDA, and the on-site inspection work has now been completed. At present, the company has 6 pharmaceutical ingredients that have entered the relevant drug supply chain in the US market through downstream customers.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.